drugset / Trial / NCT01243658

"The Effects of Oxytocin on Patients With Borderline Personality Disorder"

NCT01243658 ↗

Completed 138 enrolled Prof. Dr. Markus Heinrichs
RandomizedParallel-groupQuadruple-blindBasic science

Summary

RCT. Two substudies (clinical and experimental). Main objective of the trial is to examine if oxytocin, compared to placebo shows any additional effect on the therapy achievements (outcome) of patients with borderline personality disorder, who receive an in-patient standard psychotherapy (Dialectical-behavioral-therapy, Marsha Linehan (2006)). Secondary objectives : Investigate if oxytocin compared to placebo enhances social trust and emotion recognition in patients with borderline personality disorder. Comparison of the effects of Oxytocin on patients with BPD and major depression.

Timeline

Start
2011-01
Primary completion
2021-04
Completion
2022-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide — —